Evaluation of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor combinations and colistin in carbapenem-non-susceptible gram-negative bacilli.
- DOI
- 10.1128/spectrum.00166-25
- Published
- 2025 Oct 7
- Container
- Microbiology spectrum
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1128/spectrum.00166-25,
title = {Evaluation of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor combinations and colistin in carbapenem-non-susceptible gram-negative bacilli.},
author = {Kim TY and Baek JY and Suh E and Lee J-K and Yu H-J and Ko J-H and Huh HJ and Lee NY},
year = {2025},
journal = {Microbiology spectrum},
doi = {10.1128/spectrum.00166-25},
url = {https://doi.org/10.1128/spectrum.00166-25}
}RIS
TY - JOUR TI - Evaluation of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor combinations and colistin in carbapenem-non-susceptible gram-negative bacilli. AU - Kim TY AU - Baek JY AU - Suh E AU - Lee J-K AU - Yu H-J AU - Ko J-H AU - Huh HJ AU - Lee NY PY - 2025 JO - Microbiology spectrum DO - 10.1128/spectrum.00166-25 UR - https://doi.org/10.1128/spectrum.00166-25 ER -
APA
TY, K., JY, B., E, S., J-K, L., H-J, Y., J-H, K., HJ, H., & NY, L. (2025). Evaluation of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor combinations and colistin in carbapenem-non-susceptible gram-negative bacilli.. Microbiology spectrum. https://doi.org/10.1128/spectrum.00166-25
Source records
- pubmed · retrieved 2026-09-26T17:01:50.402Z